Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Oncology Reports
Published in: Current Oncology Reports 5/2020

01-05-2020 | NSCLC | Correction

Correction to: The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring

Authors: Jillian Wilhelmina Paulina Bracht, Clara Mayo-de-las-Casas, Jordi Berenguer, Niki Karachaliou, Rafael Rosell

Published in: Current Oncology Reports | Issue 5/2020

Login to get access

Excerpt

Correction to: Current Oncology Reports (2018) 20: 70 …
Metadata
Title
Correction to: The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring
Authors
Jillian Wilhelmina Paulina Bracht
Clara Mayo-de-las-Casas
Jordi Berenguer
Niki Karachaliou
Rafael Rosell
Publication date
01-05-2020
Publisher
Springer US
Keywords
NSCLC
NSCLC
Published in
Current Oncology Reports / Issue 5/2020
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-020-00914-x

Other articles of this Issue 5/2020

Current Oncology Reports 5/2020 Go to the issue

Interventional Oncology (DC Madoff, Section Editor)

Percutaneous Management of Cancer Pain

Lung Cancer (H Borghaei, Section Editor)

Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non–small Cell Lung Cancer

Neuro-oncology (Y Umemura, Section Editor)

Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement

Gastrointestinal Cancers (J Meyer, Section Editor)

Updates on Imaging of Liver Tumors

Breast Cancer (B Overmoyer, Section Editor)

Applying the New Guidelines of HER2 Testing in Breast Cancer

Lymphomas (MR Smith, Section Editor)

Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits